Golden
LoginSign Up
Lygos

Lygos

An industrial biotech company developing a commercial bioprocess for manufacturing bio-based malonic acid.

Lygos is an industrial biotechnology company developing a commercial bioprocess for manufacturing bio-based malonic acid. It was founded in 2010 by Eric Steen, Jay Keasling, and Jeffrey Dietrich in Berkeley, California.

Chemical production

Lygos received support from the United States Department of Energy (DOE) for their work on microbial fermentation technology to produce malonic acid. The bioprocess will lower the environmental impact and cost of manufacturing the specialty chemical compared to petroleum-based production processes.

Funding

Seed

Lygos received $120k in seed funding from Y Combinator, FundersClub, Fifty Years, Brainchild Holdings, and 10xGroup.

Series A

Lygos Series A raised $13 million led by OS Fund and IA Ventures along with First Round Capital, Y Combinator's Continuity Fund, Fifty Years, Vast Ventures, and others.

Series B

The funding round led by IA Ventures and First Round Capital, along with Y Combinator Continuity Fund and OS Fund closed at $15.5 million dollars in July 2018.

Timeline

People

Name
Role
Related Golden topics

Eric Steen

CEO

Felix Haas

Investor

Feng Hu

Investor

Jana Messerschmidt

Investor

Jared Friedman

Investor

Jay Keasling

Jeffrey Dietrich

Jude Gomila

Investor

Kal Vepuri

Investor

Oliver Tamimi

Investor

Paul Buchheit

Investor

Phineas Barnes

Investor

Robert Wuttke

Investor

Shihao Liu

Investor

Tim Abbott

Investor

Todd Corenson

Investor

Further reading

Title
Author
Link
Type

Visolis, Lygos pick up support via DOE’s Small Business Vouchers Pilot Program, as DOE opens funding Round 2

Jim Lane

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References